| Name | Title | Contact Details |
|---|
Shift (NASDAQ: SFT) is a leading end-to-end auto ecommerce platform transforming the used car industry with a technology-driven, hassle-free customer experience. Shift`s mission is to make car purchase and ownership simple — to make buying or selling a used car fun, fair, and accessible to everyone. Shift provides comprehensive, digital solutions throughout the car ownership lifecycle: finding the right car, having a test drive brought to you before buying the car, a seamless digitally-driven purchase transaction including financing and vehicle protection products, an efficient, digital trade-in/sale transaction, and a vision to provide high-value support services during car ownership.
Dynamic Ventures is a Cupertino, CA-based company in the Software and Internet sector.
Buildout is an open-source software build tool. Buildout is created using the Python programming language.
Headquartered in Alexandria, VA, UIC Technical Services (UICTS) is an Alaska Native 8(a) Holding Company committed to delivering the best quality, the best value and the best product tailored to our client's needs. UICTS and its Bowhead family of companies provide defense, government and private sector customers with expertise in areas such as program management, systems engineering/ integration, weapon systems acquisition management, logistics/supply support, software development, IT services support, risk management, training/simulation support, products procurement, and administrative services support. UICTS and its Bowhead companies are subsidiaries of the Ukpeagvik Inupiat Corporation of Barrow, Alaska.
Perthera, Inc. is a service company that helps guide patients and their physicians to the best cancer treatment options available by bridging the gap between molecular testing and patient therapy. We provide a more complete view of the molecular pathways driving advanced stage cancer than any other company. By combining genomics, proteomics and clinical history, Perthera delivers a comprehensive molecular analysis of a patient`s tumor and identifies the best available FDA approved therapies and clinical trials for each individual patient.